Sie suchten nach: apache (Englisch - Maltesisch)

apache ii score ≤ 20
skor apache ii ≤ 20

apache ii score  20
skor apache ii  20

of the species oncorhynchus apache or oncorhynchus chrysogaster
tal-ispeċi oncorhynchus apache jew oncorhynchus chrysogaster

apache ii score ≤ 20 apache ii score > 20
skor apache ii ≤ 20 skor apache ii > 20

the majority of patients had apache ii scores ≤ 20 and very few were neutropenic.
il-maġġoranza tal-pazjenti kellhom punteġġi apache ii ta’ ≤ 20 u ftit biss kienu newtropeniċi.

approximately 87% of patients had apache ii scores of ≤ 10 and 4.0% had bacteraemia at baseline.
bejn wieħed u ieħor 87% tal-pazjenti ciai kellhom punteġġi apache ii ta’ ≤ 10 u 4.0% kellhom il-batterimja fil-linja bażi.

(the apache ii score is designed to assess the risk of mortality based on acute physiology and chronic health evaluation).
(il- marka ta ’ apache ii hija maħsuba li tkejjel ir- riskju tal- mortalità a bażi ta ’ l - evalwazzjoni tal- fiżjoloġija akuta u tas- saħħa kronika).

significant absolute death reduction was limited to the subgroup of patients with greater disease severity i. e. baseline apache ii score ≥ 25 or at least 2 acute organ dysfunctions at baseline.
it- tnaqqis sinifikanti assolut fl- imwiet kien limitat għas- sottogrupp ta ’ pazjenti b’ mard aktar gravi i. e., linja bażi ta ’ apache ii > 25 jew dawk b’ mill- inqas żewġ organi li ma jiffunzjonawx b’ mod akut fil - linja bażi.

in the subgroup of patients with an apache ii score ≥25 at baseline, the mortality was 31% in the xigris group (128 out of 414) and 44% in the placebo group (176 out of 403).
fis-sottogrupp ta’ pazjenti b’marka bażi ta’ apache ii >25, il-mortalità kienet ta’ 31% fil-grupp xigris (128 minn 414) u ta’ 44% fil-grupp tal- plaċebo (176 minn 403).